Back to results
US 2019/0316134 A1Published application
Combination comprising immunostimulatory oligonucleotides
AssigneeMologen AG
InventorsMatthias SCHROFF, Manuel SCHMIDT, Kerstin KAPP, Alfredo ZURLO
Life of this patent
Estimating the term…
Abstract
The invention relates to a combination and its use for the treatment of diseases. The instant disclosure provides a combination of a so-called T-cell regulator selected from the group comprising PD1, PD-L1, OX40, TIM-3, LAGS, CD137(4-1BB) and a non-codiung immuno-modulating DNA.
Claims2
1-22. (canceled)
A linear open-chained non-coding sequence of deoxyribonucleic acids selected from SEQ ID NO:
- 7, SEQ ID NO:
- 8, SEQ ID NO:
- 9 and SEQ ID NO:
- 11.
1 more element
Dependencies are inferred from the claim text.